128 related articles for article (PubMed ID: 37217257)
1. A model for the return and referral of all clinically significant secondary findings of genomic sequencing.
Kodida R; Reble E; Clausen M; Shickh S; Mighton C; Sam J; Forster N; Panchal S; Aronson M; Semotiuk K; Graham T; Silberman Y; Randall Armel S; McCuaig JM; Cohn I; Morel CF; Elser C; Eisen A; Carroll JC; Glogowski E; Schrader KA; Di Gioacchino V; Lerner-Ellis J; Kim RH; Bombard Y;
J Med Genet; 2023 Aug; 60(8):733-739. PubMed ID: 37217257
[TBL] [Abstract][Full Text] [Related]
2. Actionable secondary findings following exome sequencing of 836 non-obstructive azoospermia cases and their value in patient management.
Kasak L; Lillepea K; Nagirnaja L; Aston KI; Schlegel PN; Gonçalves J; Carvalho F; Moreno-Mendoza D; Almstrup K; Eisenberg ML; Jarvi KA; O'Bryan MK; Lopes AM; Conrad DF; ; Punab M; Laan M
Hum Reprod; 2022 Jun; 37(7):1652-1663. PubMed ID: 35535697
[TBL] [Abstract][Full Text] [Related]
3. Pilot Study of Return of Genetic Results to Patients in Adult Nephrology.
Nestor JG; Marasa M; Milo-Rasouly H; Groopman EE; Husain SA; Mohan S; Fernandez H; Aggarwal VS; Ahram DF; Vena N; Bogyo K; Bomback AS; Radhakrishnan J; Appel GB; Ahn W; Cohen DJ; Canetta PA; Dube GK; Rao MK; Morris HK; Crew RJ; Sanna-Cherchi S; Kiryluk K; Gharavi AG
Clin J Am Soc Nephrol; 2020 May; 15(5):651-664. PubMed ID: 32299846
[TBL] [Abstract][Full Text] [Related]
4. Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings.
Reble E; Gutierrez Salazar M; Zakoor KR; Khalouei S; Clausen M; Kodida R; Shickh S; Mighton C; Cohn I; Schrader KA; Kim RH; Lerner-Ellis J; Bombard Y
Hum Genet; 2021 Mar; 140(3):493-504. PubMed ID: 32892247
[TBL] [Abstract][Full Text] [Related]
5. Frequency of genomic secondary findings among 21,915 eMERGE network participants.
eMERGE Clinical Annotation Working Group
Genet Med; 2020 Sep; 22(9):1470-1477. PubMed ID: 32546831
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.
Sam J; Reble E; Kodida R; Shaw A; Clausen M; Salazar MG; Shickh S; Mighton C; Carroll JC; Armel SR; Aronson M; Capo-Chichi JM; Cohn I; Eisen A; Elser C; Graham T; Ott K; Panchal S; Piccinin C; Schrader KA; Kim RH; Lerner-Ellis J; Bombard Y;
Hum Genet; 2022 Dec; 141(12):1875-1885. PubMed ID: 35739291
[TBL] [Abstract][Full Text] [Related]
7. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
[TBL] [Abstract][Full Text] [Related]
8. Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings.
Cléophat JE; Dorval M; El Haffaf Z; Chiquette J; Collins S; Malo B; Fradet V; Joly Y; Nabi H
BMC Med Genomics; 2021 Jun; 14(1):167. PubMed ID: 34174888
[TBL] [Abstract][Full Text] [Related]
9. Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study.
Kim Y; Kim JM; Cho HW; Park HY; Park MH
Hum Genet; 2023 Nov; 142(11):1561-1569. PubMed ID: 37728764
[TBL] [Abstract][Full Text] [Related]
10. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
[TBL] [Abstract][Full Text] [Related]
11. Challenges of secondary finding disclosure in genomic medicine in rare diseases: A nation-wide survey of Japanese facilities outsourcing comprehensive genetic testing.
Hiromoto K; Yamada T; Tsuchiya M; Kawame H; Nanba E; Goto Y; Kosugi S
J Hum Genet; 2023 Jan; 68(1):1-9. PubMed ID: 36192516
[TBL] [Abstract][Full Text] [Related]
12. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study.
Saelaert M; Mertes H; Moerenhout T; De Baere E; Devisch I
BMC Med Ethics; 2020 Jan; 21(1):9. PubMed ID: 32000764
[TBL] [Abstract][Full Text] [Related]
13. Secondary genomic findings in the 2020 China Neonatal Genomes Project participants.
Xiao H; Zhang JT; Dong XR; Lu YL; Wu BB; Wang HJ; Zhao ZY; Yang L; Zhou WH
World J Pediatr; 2022 Oct; 18(10):687-694. PubMed ID: 35727495
[TBL] [Abstract][Full Text] [Related]
14. A systematic literature review of disclosure practices and reported outcomes for medically actionable genomic secondary findings.
Sapp JC; Facio FM; Cooper D; Lewis KL; Modlin E; van der Wees P; Biesecker LG
Genet Med; 2021 Dec; 23(12):2260-2269. PubMed ID: 34433902
[TBL] [Abstract][Full Text] [Related]
15. Preconception genome medicine: current state and future perspectives to improve infertility diagnosis and reproductive and health outcomes based on individual genomic data.
Capalbo A; Poli M; Riera-Escamilla A; Shukla V; Kudo Høffding M; Krausz C; Hoffmann ER; Simon C
Hum Reprod Update; 2021 Feb; 27(2):254-279. PubMed ID: 33197264
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
[TBL] [Abstract][Full Text] [Related]
17. Raising Genomic Citizens: Adolescents and the Return of Secondary Genomic Findings.
Sabatello M; Appelbaum PS
J Law Med Ethics; 2016 Jun; 44(2):292-308. PubMed ID: 27338605
[TBL] [Abstract][Full Text] [Related]
18. Experiences and lessons learned by genetic counselors in returning secondary genetic findings to patients.
Rost C; Dent KM; Botkin J; Rothwell E
J Genet Couns; 2020 Dec; 29(6):1234-1244. PubMed ID: 32453499
[TBL] [Abstract][Full Text] [Related]
19. Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves.
Schupmann W; Miner SA; Sullivan HK; Glover JR; Hall JE; Schurman SH; Berkman BE
Genet Med; 2021 Dec; 23(12):2281-2288. PubMed ID: 34326490
[TBL] [Abstract][Full Text] [Related]
20. Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findings.
Sebastian A; Carroll JC; Vanstone M; Clausen M; Kodida R; Reble E; Mighton C; Shickh S; Aronson M; Eisen A; Elser C; Lerner-Ellis J; Kim RH; Bombard Y
Eur J Hum Genet; 2022 May; 30(5):595-603. PubMed ID: 33776058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
